Integrated Marketing & Social Media: What You Need to Know about Building Your Startup’s Visibility and Brand Thursday, June 12, 2014, 8 AM to 10:00 AM Where: 100 Cummings Center, Beverly — Conference Room 221 E As you know all too well, building your startup’s brand and visibility (with customers, investors, and potential business partners) can be daunting and overwhelming, especially when funds are tight and resources are scarce. Take Heart! An integrated marketing approach focused on social media is a great place to start. With well over one billion users worldwide, platforms such as Facebook, Twitter, LinkedIn, Google+ and YouTube are proven marketing tools for brands of all shapes and sizes. Cost efficient, these channels can quickly build Internet presence for your new venture and help you position yourself in front of the right eyes.
You are invited to attend an NSIV InnoVentures U Program Featuring MathWorks MATLAB & Simulink Upclose & Personal: MathWorks Demonstrates How to Use MATLAB & Simulink to Accelerate the Growth of Your Startup Thursday, May 8, 2014, 8 AM to 10:00 AM Where: 100 Cummings Center, Beverly — Conference Room 221 E Join us for a MathWorks presentation on MATLAB and Simulink, the leading solutions for technical computing and Model-Based Design. MATLAB and Simulink are trusted by over a million engineers and scientists worldwide to develop mission critical systems for the automotive, aerospace, industrial machinery, energy, medical device, and pharmaceutics industries.
AdvaStim’s CTO Barry Yomtov to Present at The Neurotech Investing & Partnering Conference 2014 in Boston on April 23
Barry Yomtov, CTO of AdvaStim, will be a presenter at The Neurotech Investing & Partnering Conference 2014 on Wednesday, April 23. Now in its 9th year, The Neurotech Conference is a two-day global forum where investors, executives, entrepreneurs, scientists, and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry.
This year’s conference - Fifteen Shades of Green - is about how energy efficiency and sustainability has evolved into an integral part of every industry helping grow the top line and breaking the long held myth that sustainability is a cost center. Exciting Keynotes: Doug Foy, Founder & CEO, Serrafix; Former Super-Secretariat of MA Jigar Shah, CEO, Carbon War Room Wide range of panel topics: Green Chemistry | Sustainable Mobility | Sustainable Energy | Keeping it Clean | Sustainable Building Design | Nature’s Design To register, go to www.babsonenergy.com.
NSIV is a proud Bronze Sponsor of the Life Science Nation’s Investor Conference that will be held on March 24, 2014. To register for this event, go to www.resiconference.com. Life Science Nation’s Redefining Early Stage Investments is an all-day event that will feature 16 unique early-stage investor panels that will offer the latest perspective on the state of investments in the industry. The conference offers a full day of partnering for companies looking to connect with service providers and investors.
NSIV presents an InnoVenutures U program: Ready, Aim, Hire! What Every Startup Needs to Know about HR Benefits & Hiring Practices BeforeYou Make an Offer Thursday, March 13, 8:00 AM – 10:00 AM Where: 100 Cummings Center, Beverly Conference Room 221 E So you’re at that exhilarating stage in your company where you can NOW hire your first round of employees. But as you would expect, hiring is serious (and legalistic) business.This seminar is designed to help small and growing businesses gain an understanding of employee benefit requirements and best hiring practice strategies.
Are you a new, emerging or growing company located in Essex County or Merrimack Valley? We are looking for companies to enter the tenth annual North of Boston Business Plan Competition. The North of Boston Business Plan Competition has a new, 21st century format! The 25- to 30-page business plan is gone! In its place is a new format that recognizes that the success of a business plan depends equally on the quality of the plan and the people who will execute it.
Entrpreneurs & Investors: You’re invited to a panel discussion featuring two winners from the 2013 Mass Challenge 7:30 a.m. – 8:00 a.m. = Breakfast/Networking 8:00 a.m. – 9:00 a.m. = Program Massachusetts has entered into a new business revolution. The changing economy and rapid rise in technology has led to an entrepreneur boom in the Bay State. With the growing boom comes a host of questions for new entrepreneurs: Whether to Participate in Accelerator Programs? How to secure investors? What is the best business model? How to protect innovative intellectual property? McLane invites entrepreneurs and investors to a panel discussion featuring three winners from the 2013 Mass Challenge. The winners, Noam Josephy, Co-Founder and Director of AMS-Qi, and Sean Kevlahan, CEO, Quad Technology will share their experiences creating a start-up organization and their experiences in the Mass Challenge, including: •Benefits and lessons learned from the Mass Challenge •Challenges faced in building a start-up •How to gain funding •Selecting the best form of a business organization •Protecting core intellectual property This event has limited space and is open on a first come, first served basis. Location: 300 TradeCenter Suite 7600 (For GPS: 100 Sylvan Road) Woburn, MA 01801 Contact: Phone: 781-904-2700 Email: Click here to start an email Website: www.mclane.com
January 21, 2014 8:30 am – 5:00pm Nutter McClennen & Fish LLP 155 Seaport Boulevard, Boston, MA 02210
You are invited to attend: InnoVentures U – The ABCs of Non-Dilutive Funding… Or, Successfully Tapping the SBIR Well Thursday, December 12, 2013, 8:00 AM – 10:00 AM Where: 100 Cummings Center (Beverly) — Conference Room 221 E The Small Business Innovation Research programs of the US government (SBIR/STTR) provide billions of dollars of research support to translate innovative ideas into useful products. However, the programs are highly competitive and applications to various governmental agencies (e.g., NIH, NSF, DoD) differ greatly, with success rates generally below 20% and falling as the sluggish economy yields fewer tax dollars dedicated to support such research.